FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307328170> ?p ?o ?g. }

• W4307328170 endingPage "66" @default.
• W4307328170 startingPage "66" @default.
• W4307328170 abstract "In order to conduct a pediatric clinical trial, it is important to optimize pediatric dose as accurately as possible. In this study, a simple weight-based method known as ‘Salisbury Rule’ was used to predict pediatric dose for therapeutic proteins and was then compared with the observed pediatric dose. The observed dose was obtained mainly from the FDA package insert and if dosing information was not available from the FDA package insert then the observed dose was based on the dose given to an age group in a particular study. It was noted that the recommended doses of most of the therapeutic proteins were extrapolated to pediatrics from adult dose based on per kilogram (kg) body weight basis. Since it is widely believed that pediatric dose should be selected based on the pediatric clearance (CL), a CL based pediatric dose was projected from the following equation: Dose in children = Adult dose × (Observed CL in children/Observed adult CL). In this study, this dose was also considered observed pediatric dose for comparison. A ±30% prediction error (predicted vs. observed) was considered acceptable. There were 21 monoclonal antibodies, 5 polyclonal antibodies in children ≥ 2 years of age, 4 polyclonal antibodies in preterm and term neonates, and 11 therapeutic proteins (non-antibodies) in the study. In children < 30 kg body weight, the predicted doses were within 0.5–1.5-fold prediction error for 87% (monoclonal antibody), 100% (polyclonal antibody), and 92% (non-antibodies) observations. In children > 30 kg body weight, the predicted doses were within 0.5–1.5-fold prediction error for 96% (monoclonal antibody), 100% (polyclonal antibody), and 100% (non-antibodies) observations. The Salisbury Rule mimics more to CL-based dose rather than per kg body weight-based extrapolated dose from adults. The Salisbury Rule for the pediatric dose prediction can be used to select first-in-children dose in pediatric clinical trials and may be in clinical settings." @default.
• W4307328170 created "2022-10-31" @default.
• W4307328170 creator A5037939650 @default.
• W4307328170 date "2022-10-21" @default.
• W4307328170 modified "2023-10-14" @default.
• W4307328170 title "A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule" @default.
• W4307328170 cites W1582179500 @default.
• W4307328170 cites W1963598954 @default.
• W4307328170 cites W1970066381 @default.
• W4307328170 cites W1975066524 @default.
• W4307328170 cites W1993117495 @default.
• W4307328170 cites W1995193364 @default.
• W4307328170 cites W2000436105 @default.
• W4307328170 cites W2003662997 @default.
• W4307328170 cites W2015488597 @default.
• W4307328170 cites W2024998043 @default.
• W4307328170 cites W2032875236 @default.
• W4307328170 cites W2033691045 @default.
• W4307328170 cites W2042658181 @default.
• W4307328170 cites W2047857407 @default.
• W4307328170 cites W2050900492 @default.
• W4307328170 cites W2053515768 @default.
• W4307328170 cites W2062756251 @default.
• W4307328170 cites W2065095349 @default.
• W4307328170 cites W2067398657 @default.
• W4307328170 cites W2071066542 @default.
• W4307328170 cites W2083402819 @default.
• W4307328170 cites W2084300880 @default.
• W4307328170 cites W2084735257 @default.
• W4307328170 cites W2092667376 @default.
• W4307328170 cites W2112631399 @default.
• W4307328170 cites W2118938307 @default.
• W4307328170 cites W2119332183 @default.
• W4307328170 cites W2121010183 @default.
• W4307328170 cites W2122527560 @default.
• W4307328170 cites W2133240055 @default.
• W4307328170 cites W2137298663 @default.
• W4307328170 cites W2140304772 @default.
• W4307328170 cites W2144016275 @default.
• W4307328170 cites W2145860152 @default.
• W4307328170 cites W2155348627 @default.
• W4307328170 cites W2167362914 @default.
• W4307328170 cites W2174460595 @default.
• W4307328170 cites W2344869076 @default.
• W4307328170 cites W2510668125 @default.
• W4307328170 cites W2621222852 @default.
• W4307328170 cites W2791923636 @default.
• W4307328170 cites W2889930082 @default.
• W4307328170 cites W2905965661 @default.
• W4307328170 cites W2972823249 @default.
• W4307328170 cites W2990202983 @default.
• W4307328170 cites W2992181489 @default.
• W4307328170 cites W3006337058 @default.
• W4307328170 cites W3046995670 @default.
• W4307328170 cites W3131415391 @default.
• W4307328170 cites W4234975938 @default.
• W4307328170 cites W5441452 @default.
• W4307328170 doi "https://doi.org/10.3390/antib11040066" @default.
• W4307328170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278619" @default.
• W4307328170 hasPublicationYear "2022" @default.
• W4307328170 type Work @default.
• W4307328170 citedByCount "1" @default.
• W4307328170 crossrefType "journal-article" @default.
• W4307328170 hasAuthorship W4307328170A5037939650 @default.
• W4307328170 hasBestOaLocation W43073281701 @default.
• W4307328170 hasConcept C126322002 @default.
• W4307328170 hasConcept C147583825 @default.
• W4307328170 hasConcept C159654299 @default.
• W4307328170 hasConcept C163864487 @default.
• W4307328170 hasConcept C203014093 @default.
• W4307328170 hasConcept C2777288759 @default.
• W4307328170 hasConcept C542903549 @default.
• W4307328170 hasConcept C71924100 @default.
• W4307328170 hasConcept C956191 @default.
• W4307328170 hasConcept C98274493 @default.
• W4307328170 hasConceptScore W4307328170C126322002 @default.
• W4307328170 hasConceptScore W4307328170C147583825 @default.
• W4307328170 hasConceptScore W4307328170C159654299 @default.
• W4307328170 hasConceptScore W4307328170C163864487 @default.
• W4307328170 hasConceptScore W4307328170C203014093 @default.
• W4307328170 hasConceptScore W4307328170C2777288759 @default.
• W4307328170 hasConceptScore W4307328170C542903549 @default.
• W4307328170 hasConceptScore W4307328170C71924100 @default.
• W4307328170 hasConceptScore W4307328170C956191 @default.
• W4307328170 hasConceptScore W4307328170C98274493 @default.
• W4307328170 hasIssue "4" @default.
• W4307328170 hasLocation W43073281701 @default.
• W4307328170 hasLocation W43073281702 @default.
• W4307328170 hasLocation W43073281703 @default.
• W4307328170 hasLocation W43073281704 @default.
• W4307328170 hasOpenAccess W4307328170 @default.
• W4307328170 hasPrimaryLocation W43073281701 @default.
• W4307328170 hasRelatedWork W1971294201 @default.
• W4307328170 hasRelatedWork W1989645200 @default.
• W4307328170 hasRelatedWork W2020465807 @default.
• W4307328170 hasRelatedWork W2025678534 @default.
• W4307328170 hasRelatedWork W2073840950 @default.
• W4307328170 hasRelatedWork W2146940419 @default.

• next